Home » ETF » SPBO

SPBO - SPDR Portfolio Corporate Bond ETF

Stock Price: $35.70 USD -0.04 (-0.10%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Assets $363.47M
NAV $35.46
Expense Ratio 0.06%
PE Ratio n/a
Beta (5Y) 0.16
Dividend (ttm) $0.93
Dividend Yield 2.61%
Ex-Dividend Date Jul 1, 2021
1-Year Return -
Trading Day July 23
Last Price $35.70
Previous Close $35.74
Change ($) -0.04
Change (%) -0.10%
Day's Open 35.70
Day's Range 35.62 - 35.72
Day's Volume 91,495
52-Week Range 33.69 - 35.88

Fund Description

The investment seeks investment results that, before fees and expenses, correspond generally to the price and yield performance of an index that tracks the Bloomberg Barclays U.S. Corporate Bond Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in securities that the Adviser determines have economic characteristics that are substantially identical to the economic characteristics of the securities that comprise the index. The index is designed to measure the performance of the investment grade corporate bond market.

Asset Class
Fixed Income
Inception Date
Apr 6, 2011
Ticker Symbol
Index Tracked
Bloomberg Barclays U.S. Corporate Bond Index

Top 10 Holdings

2.44% of assets
Citigroup Inc. 3.2%n/a0.32%
Wells Fargo & Company 4.65%n/a0.28%
AT&T Inc 3.8%n/a0.25%
Morgan Stanley 6.38%n/a0.24%
Goldman Sachs Group, Inc. 6.75%n/a0.23%
HSBC Holdings plc 6.5%n/a0.23%
Intel Corporation 2.45%n/a0.22%
Goldman Sachs Group, Inc. 6.45%n/a0.22%
Verizon Communications Inc. 4.12%n/a0.22%
Barclays PLC 5.2%n/a0.22%
View More Holdings


Ex-DividendAmountPay Date
Jul 1, 2021$0.071Jul 8, 2021
Jun 1, 2021$0.07Jun 7, 2021
May 3, 2021$0.071May 7, 2021
Apr 1, 2021$0.07Apr 8, 2021
Mar 1, 2021$0.073Mar 5, 2021
Feb 1, 2021$0.072Feb 5, 2021
Full Dividend History


Hide News

The 0.03% price makes SPAB and SPBO cheaper than competing funds.

Other tickers mentioned: SPAB
3 weeks ago - ETFcom

Amid very-low interest rate environment, investors may be interested in securities that have the potential to offer capital appreciation as well as benchmark-beating yields.

Other tickers mentioned: CDC, IVOL, QDEF, VRP
1 year ago - Zacks Investment Research